Skip to content
Recall Observatory FDA recall evidence

Drug product

Naproxen Sodium Tablets, USP 275 mg 100 Tablets Rx Only NDC 68462-178-01 Manufactured by: Glenmark Pharmaceuticals Inc., USA 4147 Goldmine Road Monroe, NC 28110 Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430

D-0821-2021

August 27, 2021

Class II

Product summary

Firm
Glenmark Pharmaceuticals Inc., USA
Event
Event 88591
Status
Terminated
Classification
Class II
Quantity
9552 bottles
Official record key
drug-enforcement:D-0821-2021

Official wording

Reason: CGMP Deviations

Code information: Lots: 29190087 Exp. 10/31/2021; 29190088 Exp. 10/31/2021; 29190089 Exp. 10/31/2021; 29200077 Exp. 11/30/2022; 29200078 Exo, 11/30/2022

Distribution pattern: Nationwide.

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations